ArticleClinical and molecular hepatology2014

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.

Hee Jae Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.